PPAR-Mediated Toxicology and Applied Pharmacology

Cells. 2020 Feb 3;9(2):352. doi: 10.3390/cells9020352.

Abstract

Peroxisome proliferator-activated receptors (PPARs), members of the nuclear hormone receptor family, attract wide attention as promising therapeutic targets for the treatment of multiple diseases, and their target selective ligands were also intensively developed for pharmacological agents such as the approved drugs fibrates and thiazolidinediones (TZDs). Despite their potent pharmacological activities, PPARs are reported to be involved in agent- and pollutant-induced multiple organ toxicity or protective effects against toxicity. A better understanding of the protective and the detrimental role of PPARs will help to preserve efficacy of the PPAR modulators but diminish adverse effects. The present review summarizes and critiques current findings related to PPAR-mediated types of toxicity and protective effects against toxicity for a systematic understanding of PPARs in toxicology and applied pharmacology.

Keywords: PPARs; ligand; pharmacology; toxicology.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Humans
  • Models, Biological
  • Organ Specificity / drug effects
  • Peroxisome Proliferator-Activated Receptors / pharmacology*
  • Peroxisome Proliferator-Activated Receptors / toxicity*
  • Pharmaceutical Preparations / chemistry
  • Protective Agents / pharmacology

Substances

  • Peroxisome Proliferator-Activated Receptors
  • Pharmaceutical Preparations
  • Protective Agents